Cardiovascular, pulmonary and renal complications of fulminant hepatic failure.
D001692:Biological Transport / Q000187:drug effects; D002318:Cardiovascular Diseases / Q000209:etiology*; D011464:Epoprostenol / Q000494:pharmacology; D006439:Hemodynamics / Q000187:drug effects; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D007674:Kidney Diseases / Q000209:etiology*; D007773:Lactates / Q000097:blood; D019344:Lactic Acid; D008107:Liver Diseases / Q000097:blood / Q000150:complications* / Q000503:physiopathology; D008171:Lung Diseases / Q000209:etiology* / Q000628:therapy; D010101:Oxygen Consumption / Q000187:drug effects
D006454:Hemoglobins; D007773:Lactates; D019344:Lactic Acid; D011464:Epoprostenol